192 related articles for article (PubMed ID: 24885569)
1. Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses.
Park SW; Kwon MJ; Yoo JY; Choi HJ; Ahn YJ
BMC Complement Altern Med; 2014 May; 14():171. PubMed ID: 24885569
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.
Ngan LT; Jang MJ; Kwon MJ; Ahn YJ
PLoS One; 2015; 10(4):e0121629. PubMed ID: 25860871
[TBL] [Abstract][Full Text] [Related]
3. Anti-human rhinovirus 2 activity and mode of action of quercetin-7-glucoside from Lagerstroemia speciosa.
Song JH; Park KS; Kwon DH; Choi HJ
J Med Food; 2013 Apr; 16(4):274-9. PubMed ID: 23566054
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication.
Choi HJ; Bae EY; Song JH; Baek SH; Kwon DH
Lett Appl Microbiol; 2010 Jul; 51(1):1-5. PubMed ID: 20497313
[TBL] [Abstract][Full Text] [Related]
5. Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity.
Choi HJ; Song JH; Bhatt LR; Baek SH
Phytother Res; 2010 Sep; 24(9):1292-6. PubMed ID: 20104501
[TBL] [Abstract][Full Text] [Related]
6. Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Choi HJ; Song JH; Lim CH; Baek SH; Kwon DH
J Med Food; 2010 Apr; 13(2):326-8. PubMed ID: 20412019
[TBL] [Abstract][Full Text] [Related]
7. Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity.
; Modi M; Goel T; Das T; Malik S; Suri S; Rawat AK; Srivastava SK; Tuli R; Malhotra S; Gupta SK
Indian J Med Res; 2013 Mar; 137(3):540-8. PubMed ID: 23640562
[TBL] [Abstract][Full Text] [Related]
8. The anti-diabetic effect of eight Lagerstroemia speciosa leaf extracts based on the contents of ellagitannins and ellagic acid derivatives.
Guo S; Ren X; He K; Chen X; Zhang S; Roller M; Zheng B; Zheng Q; Ho CT; Bai N
Food Funct; 2020 Feb; 11(2):1560-1571. PubMed ID: 32003379
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts.
Walther C; Döring K; Schmidtke M
BMC Complement Med Ther; 2020 Dec; 20(1):380. PubMed ID: 33357221
[TBL] [Abstract][Full Text] [Related]
10. Iota-Carrageenan is a potent inhibitor of rhinovirus infection.
Grassauer A; Weinmuellner R; Meier C; Pretsch A; Prieschl-Grassauer E; Unger H
Virol J; 2008 Sep; 5():107. PubMed ID: 18817582
[TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers.
Unno T; Sugimoto A; Kakuda T
J Ethnopharmacol; 2004 Aug; 93(2-3):391-5. PubMed ID: 15234783
[TBL] [Abstract][Full Text] [Related]
12. Rhinovirus chemotherapy.
Patick AK
Antiviral Res; 2006 Sep; 71(2-3):391-6. PubMed ID: 16675037
[TBL] [Abstract][Full Text] [Related]
13. Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells.
Bai N; He K; Roller M; Zheng B; Chen X; Shao Z; Peng T; Zheng Q
J Agric Food Chem; 2008 Dec; 56(24):11668-74. PubMed ID: 19053366
[TBL] [Abstract][Full Text] [Related]
14. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.
Phillips T; Jenkinson L; McCrae C; Thong B; Unitt J
J Virol Methods; 2011 May; 173(2):182-8. PubMed ID: 21300110
[TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses.
Becker TM; Durrani SR; Bochkov YA; Devries MK; Rajamanickam V; Jackson DJ
Ann Allergy Asthma Immunol; 2013 Nov; 111(5):397-401. PubMed ID: 24125148
[TBL] [Abstract][Full Text] [Related]
17. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
[TBL] [Abstract][Full Text] [Related]
18. Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Mello C; Aguayo E; Rodriguez M; Lee G; Jordan R; Cihlar T; Birkus G
Antimicrob Agents Chemother; 2014; 58(3):1546-55. PubMed ID: 24366736
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.
Spickler C; Lippens J; Laberge MK; Desmeules S; Bellavance É; Garneau M; Guo T; Hucke O; Leyssen P; Neyts J; Vaillancourt FH; Décor A; O'Meara J; Franti M; Gauthier A
Antimicrob Agents Chemother; 2013 Jul; 57(7):3358-68. PubMed ID: 23650168
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-rhinovirus activity of novel 3-[2-(pyridinyl)vinyl]substituted -2H-chromenes and -4H-chromen-4-ones.
Conti C; Proietti Monaco L; Desideri N
Bioorg Med Chem; 2014 Feb; 22(3):1201-7. PubMed ID: 24360829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
